The domestic launch time and approval information of canafenib/encofenib

Canafenib (Encorafenib) is a BRAF inhibitor, mainly used to treat melanoma and some other solid tumors carrying BRAF V600 mutations. in the country, canafenib has recently been officially approved for marketing after undergoing strict drug approval procedures. This marks a new option for domestic patients in targeted therapy, especially for patients with BRAF mutant melanoma, and its clinical application prospects are broad.

According to information released by the National Medical Products Administration (NMPA), the approval of canafenib went through drug clinical trials, registration applications and strict review. Domestic marketing approval emphasizes the safety, effectiveness and quality control of drugs, so patients can maintain confidence in the quality and source of drugs when using them. However, because it has just been launched, the drug's availability in domestic hospitals and pharmacies is relatively limited, and purchase requires formal hospital prescription channels.

In terms of price, the domestic market supply of canafenib’s original drug is relatively small, so the price is relatively high. Taking the European version as an example, the price of 75mgspecifications 42 capsules and 168 capsules may reach more than 10,000 yuan and 40,000 yuan respectively. Price fluctuations may also be affected by exchange rate changes. This puts great financial pressure on some patients, and treatment options need to be considered in conjunction with medical insurance policies or other assistance plans.

In order to reduce the cost of medication, some patients will consider generic drug channels. The main generic version of Canafenib currently on the market is the Laotian version, which costs about 4,000 yuan per box, and the drug ingredients are basically the same as the original drug. When choosing purchase channels, patients should ensure that they obtain drugs through formal channels to ensure the safety and efficacy of the drugs. At the same time, they can reasonably arrange medication plans under the guidance of doctors to ensure maximum treatment effects.

Reference materials:https://www.drugs.com/